|
MINA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.29170049393224E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19904086659517E-14 |
| Normal-vs-Stage2 |
1.60708999999981E-05 |
| Normal-vs-Stage3 |
7.21345205789703E-12 |
| Normal-vs-Stage4 |
1.65423230669148E-12 |
| Stage1-vs-Stage2 |
1.941980E-01 |
| Stage1-vs-Stage3 |
4.694000E-02 |
| Stage1-vs-Stage4 |
1.00110000000875E-06 |
| Stage2-vs-Stage3 |
2.092200E-02 |
| Stage2-vs-Stage4 |
4.221900E-04 |
| Stage3-vs-Stage4 |
2.629600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.15939496786655E-11 |
| Normal-vs-AfricanAmerican |
1.0733003374952E-10 |
| Normal-vs-Asian |
2.17814655201209E-12 |
| Caucasian-vs-AfricanAmerican |
4.664000E-01 |
| Caucasian-vs-Asian |
3.217800E-02 |
| AfricanAmerican-vs-Asian |
4.402200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0079004297836E-10 |
| Normal-vs-Female |
8.68299876444212E-11 |
| Male-vs-Female |
6.950000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.82760489969769E-11 |
| Normal-vs-Age(41-60Yrs) |
5.6621374255883E-14 |
| Normal-vs-Age(61-80Yrs) |
6.63070043316338E-10 |
| Normal-vs-Age(81-100Yrs) |
3.675700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.075800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.054000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.676000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.591400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.956200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.853000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.90219999979458E-07 |
| Classical-VS-Follicular |
4.94009999996159E-06 |
| Classical-VS-Other |
9.684200E-01 |
| Classical-VS-Normal |
9.65749702430685E-12 |
| Tall-VS-Follicular |
3.68379993176404E-10 |
| Tall-VS-Other |
4.452000E-01 |
| Tall-VS-Normal |
1.63158375698913E-12 |
| Follicular-VS-Other |
1.615600E-01 |
| Follicular-VS-Normal |
1.459320E-03 |
| Other-VS-Normal |
2.757900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52540002851254E-09 |
| Normal-vs-N1 |
1.6672219160796E-12 |
| N0-vs-N1 |
2.05090000005015E-06 |
|
|
